COREABI: COgnitive REhabilitation in Pediatric Patients With sABI From Vegetative State to Functional Recovery

Sponsor
IRCCS Eugenio Medea (Other)
Overall Status
Recruiting
CT.gov ID
NCT04499092
Collaborator
(none)
80
1
2
45
1.8

Study Details

Study Description

Brief Summary

Acquired brain lesions (GCLA) represent one of the most important cause of disability and mortality during the pediatric age, also in the western Countries. The important medical progresses of the last decade in the medical field have increased the percentages of survival, also in the most severe clinical pictures. On the other hand, a brain lesion reported in the first years of life presents with a more dramatic impact on the cognitive and neurological development of the patients and it can significantly interfere with the same quality of their life. Recent studies suggest that a brain damage in this stage of the life is related to more persistent sequelae in comparison of the same lesion reported by an adult patient, because of the neurological immaturity at the moment of the insult. Furthermore, in most cases, the brain lesion is related not only to motor and sensorial deficits but also to very important behavioral and cognitive problems, that can arise immediately after the acute phase, or also several years after the pathological event.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Neuropsychological treatment
N/A

Detailed Description

The aims of the present study are:
  1. To contribute to the adaptation of the Italian version of the Coma Recovery Scale (CRS-R) for the pediatric age, with specific differentiation and taking into account the age of the patients and the specific learning that characterize each developmental stage;

  2. As regards the patients with an adequate cognitive profile, to compare the effectiveness of a traditional multifunction neuropsychological treatment (cognitive functions are stimulated at the same time) vs a sequential treatment (cognitive functions are stimulated step by step).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Validation of assessement scale; study of the effectivness of two models of neuropsychological interventionValidation of assessement scale; study of the effectivness of two models of neuropsychological intervention
Masking:
Single (Participant)
Masking Description:
Caregivers of participants don't know what kind of treatment will be proposed.
Primary Purpose:
Treatment
Official Title:
COgnitive REhabilitative Treatments in Pediatric Patients With Severe Acquired Brain Injury From Vegetative State to Functional Recovery
Actual Study Start Date :
Oct 1, 2019
Anticipated Primary Completion Date :
Feb 28, 2022
Anticipated Study Completion Date :
Jul 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Multifunction treatment

Patients that will receive a simulataneous multifunction treatment

Behavioral: Neuropsychological treatment
Neuropsychological treatment

Experimental: Sequential treatment

Patients will receive a sequential function by function treatment

Behavioral: Neuropsychological treatment
Neuropsychological treatment

Outcome Measures

Primary Outcome Measures

  1. Multifunction treatment (Attention) [immediately after the intervention]

    Continuous Performance Test 2nd Edition (CPT, Conners, 2000): is a neuropsychological test that measures a person's sustained and selective attention. Sustained attention is the ability to maintain a consistent focus on some continuous activity or stimuli, and is associated with impulsivity. Selective attention is the ability to focus on relevant stimuli and ignore competing stimuli. This skill is associated with distractibility

  2. Multifunction treatment (Attention) [immediately after the intervention]

    Developmental Age Neuropsychological Evaluation Battery (DANEB, Gugliotta et al. 2005) is a test battery for the neuropsychological evaluation of the main cognitive functions (language, visual perception, memory, neuro-motor associations, attention, higher executive functions, reading, writing and calculation) in children from 5 to 11 years old. It helps analyze the development of cognitive functions and the detection of developmental or acquired cognitive pathologies.

  3. Multifunction treatment (Memory) [immediately after intervention]

    Rey-Osterrieth complex figure test (ROCF, Rey, 1941) is a neuropsychological assessment in which examinees are asked to reproduce a complicated line drawing, first by copying it freehand (recognition), and then drawing from memory (recall).

  4. Multifunction treatment (Memory) [immediately after intervention]

    Corsi Test (De Renzi & Nicheli, 1975) is a neuropsychological assessment that measures the visual spatial span, that is the quantity of visual and spatial information that it is possible to maintain in the Short-Term Memory

  5. Multifunction treatment (Memory) [immediately after intervention]

    Digit Sequencing or Digit Span test (Blackburn, 1957) is one of the main tools developed to measure one's verbal working memory. The test was originally designed to test working memory and attention, as part of the Wechsler Intelligence Scale. Usually, the examiner reads a list of numbers, and the participant repeats them until an incorrect answer is given.

  6. Multifunction treatment (Memory) [immediately after intervention]

    Developmental Age Neuropsychological Evaluation Battery (DANEB, Gugliotta et al. 2005): see above

  7. Multifunction treatment (Executive Functions) [immediately after intervention]

    Tower of London test (Shallice, 1982) is a test used in applied clinical neuropsychology for the assessment of executive functioning specifically to detect deficits in planning.

  8. Multifunction treatment (Executive Functions) [immediately after intervention]

    Wisconsin Card Sorting Test (WCST, Kongs, Thompson, Iverson, & Heaton, 2000) is a neuropsychological test that is frequently used to measure such higher-level cognitive processes as attention, perseverance, WM, abstract thinking, and set shifting.

  9. Multifunction treatment (Executive Functions) [immediately after intervention]

    Behavior Rating Inventory of Executive Function (BRIEF; Gioia et al. 2000) is an assessment of executive function behaviors at home and at school for children and adolescents ages 5-18.

  10. Multifunction treatment (Executive Functions) [immediately after intervention]

    Developmental NEuroPSYchological Assessment (NEPSY, Korkman, Kirk & Kemp, 1998) is a series of neuropsychological tests that are used in various combinations to assess neuropsychological development in children ages 3-16 years in six functional domains.

  11. Multifunction treatment (Visual perceptual functions) [immediately after intervention]

    Test of Visual Perceptual Skills (TVPS-4, Martin, 2008) is the latest update of the standard comprehensive assessment of visual analysis and processing skills. The TVPS-4 remains an easy-to-use assessment for determining visual-perceptual strengths and weaknesses.

  12. Multifunction treatment (Visual perceptual functions) [immediately after intervention]

    Benton Visual Retention Test (Benton test or BVRT, Benton, 1946) is an individually administered test for people aged from eight years to adulthood that measures visual perception and visual memory. It can also be used to help identify possible learning disabilities among other afflictions that might affect an individual's memory.

  13. Multifunction treatment (Visual perceptual functions) [immediately after intervention]

    Rey-Osterrieth complex figure test (ROCF, Rey, 1941): see above

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Months to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
For the adaptation of the CRS-R:
Healthy subjects:
  • children aged between 0 and 5 years (N=48);

  • normal development.

Clinical subjects:
  • Age between 0 and 10 at the moment of the pathological event;

  • LOCFAS score <5;

  • A documented diagnosis of severe acquired brain lesion of traumatic, anoxic, vascular or infective etiology (Glasgow Coma Scale, GCS<12);

  • Brain lesion reported within one year from the day of the inclusion in the study.

For the comparison between multifunction treatment vs sequential treatment:
  • Age between 5 and 18 years at the moment of the pathological event;

  • LOCFAS score>5

  • time between the GCLA and the assessment < 3 months

  • Documented GCLA

  • GCS <12 in the acute phase

  • Negative anamnesis for other developmental disorders before the GCLA

Contacts and Locations

Locations

Site City State Country Postal Code
1 IRCCS Eugenio Medea Bosisio Parini Italy 23842

Sponsors and Collaborators

  • IRCCS Eugenio Medea

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
IRCCS Eugenio Medea
ClinicalTrials.gov Identifier:
NCT04499092
Other Study ID Numbers:
  • 607rev1
First Posted:
Aug 5, 2020
Last Update Posted:
Aug 25, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by IRCCS Eugenio Medea
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 25, 2021